FASTCLAV 125

Main information

  • Trade name:
  • FASTCLAV 125 30 ML D.SYR
  • Pharmaceutical form:
  • D.SYR
  • Composition:
  • 30 ML
  • Medicine domain:
  • Humans
  • Medicine type:
  • Allopathic drug

Documents

Localization

  • Available in:
  • FASTCLAV 125 30 ML D.SYR
    India
  • Language:
  • English

Other information

Status

  • Source:
  • Central Drugs Standard Control Organization
  • Last update:
  • 09-08-2016

6-3-2018

Sagent Pharmaceuticals Issues Voluntary Nationwide Recall of Methylprednisolone Sodium Succinate for Injection, USP, 40mg, 125mg, and 1g Due to High Out of Specification Impurity Results

Sagent Pharmaceuticals Issues Voluntary Nationwide Recall of Methylprednisolone Sodium Succinate for Injection, USP, 40mg, 125mg, and 1g Due to High Out of Specification Impurity Results

Sagent Pharmaceuticals, Inc. today announced the voluntary nationwide recall of ten lots of Methylprednisolone Sodium Succinate for Injection, USP, 40mg, 125mg, and 1g. A detailed listing of products and lots is listed below. These products were manufactured by Gland Pharma Ltd. and distributed by Sagent Pharmaceuticals.

FDA - U.S. Food and Drug Administration

6-3-2018

Methylprednisolone Sodium Succinate for Injection 40mg, 125mg, and 1g by Sagent Pharmaceuticals: Recall - High Out of Specification Impurity Results

Methylprednisolone Sodium Succinate for Injection 40mg, 125mg, and 1g by Sagent Pharmaceuticals: Recall - High Out of Specification Impurity Results

An elevated impurity has the potential to decrease effectiveness of the product in patients. Posted: 03/06/2018

FDA - U.S. Food and Drug Administration

7-2-2018

CA 125

CA 125

Title: CA 125Category: Procedures and TestsCreated: 1/21/1999 12:00:00 AMLast Editorial Review: 2/7/2018 12:00:00 AM

US - MedicineNet

18-10-2017

EU/3/17/1918 (CellProtect Nordic Pharmaceuticals AB)

EU/3/17/1918 (CellProtect Nordic Pharmaceuticals AB)

EU/3/17/1918 (Active substance: Autologous ex-vivo-expanded peripheral polyclonal lymphocytes enriched in activated natural killer cells) - Orphan designation - Commission Decision (2017)7051 of Wed, 18 Oct 2017 European Medicines Agency (EMA) procedure number: EMA/OD/125/17

Europe -DG Health and Food Safety

17-7-2017

DILANTIN-125 (Phenytoin) Suspension [Parke-Davis Div Of Pfizer Inc]

DILANTIN-125 (Phenytoin) Suspension [Parke-Davis Div Of Pfizer Inc]

Updated Date: Jul 17, 2017 EST

US - DailyMed